PMID: 9436851Jan 22, 1998Paper

Current options for the topical treatment of acne vulgaris

Pediatric Dermatology
J S Weiss

Abstract

The etiopathogenesis of acne vulgaris, a common disorder of youth and adolescence, includes four primary processes: hyperkeratinization (plugging) of the pilosebacous follicles, increased testosterone levels, bacterial colonization with Propionibacterium acnes, and inflammation. No single agent has yet been developed that addresses all of these factors. Combination regimens, therefore, which usually include an antibiotic and an agent to reduce follicular plugging, have become the mainstay of treatment. Despite a relative dearth of new treatments for almost a decade, recent research has produced a number of new significant oral and topical agents. Azelaic acid, a naturally occurring dicarboxylic acid analogue, has shown promise, and a group of retinoids that include adapalene, tazarotene, and reformulations of tretinoin represent new and forthcoming agents for topical treatment of acne vulgaris. Some studies indicate that several of these agents are associated with less skin irritation than previous formulations while they retain potent comedolytic activity. Adapalene also possesses significant anti-inflammatory activity.

References

Oct 1, 1992·Postgraduate Medicine·B H Kumasaka, P B Odland
Apr 1, 1991·The British Journal of Dermatology·M VerschooreH Schaefer
Oct 1, 1986·Journal of the American Academy of Dermatology·J J Leyden, A R Shalita
Mar 1, 1987·Revista clínica española·E Zamora MartínezA de Castro Torres
Apr 1, 1986·Clinics in Dermatology·A Lahti
Apr 1, 1969·Kango kyoshitsu. [Nursing classroom]·K Fujita
Aug 1, 1972·Archives of Dermatology·O H MillsA M Kligman
Mar 1, 1974·The Journal of Investigative Dermatology·D D Knutson
Aug 1, 1982·The British Journal of Dermatology·E A EadyW J Cunliffe
Jan 1, 1983·International Journal of Dermatology·R L Rietschel, S H Duncan
Oct 1, 1984·International Journal of Dermatology·C R Darley
Jun 1, 1983·Journal of the American Academy of Dermatology·B E ElewskiW R Gammon
Jan 1, 1993·Skin Pharmacology : the Official Journal of the Skin Pharmacology Society·B A Bernard
Feb 1, 1994·Pediatrics in Review·S Hurwitz
Jun 1, 1997·Journal of the American Academy of Dermatology·B Shroot, S Michel
Feb 18, 2004·Journal of Cataract and Refractive Surgery·Takeshi TanakaYoshitaka Ohnishi
Jan 1, 1984·International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience·J Rosenfeld, V L Friedrich

❮ Previous
Next ❯

Citations

Aug 16, 2000·Pediatric Clinics of North America·D P Krowchuk
Mar 15, 2003·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Witold Musiał, Aleksander Kubis
Feb 15, 2002·Journal of the European Academy of Dermatology and Venereology : JEADV·J J Leyden
Nov 30, 2000·International Journal of Dermatology·L E Millikan
Dec 21, 2002·International Journal of Dermatology·Ali M Al-Ameer, Omar M Al-Akloby
Jul 4, 1998·Lancet·S K Brown, A R Shalita
Sep 18, 2010·Mediators of Inflammation·Aswin HariP Régine Mydlarski
Aug 10, 2007·Cutaneous and Ocular Toxicology·Parham Mirshahpanah, Howard I Maibach
May 22, 2008·International Journal of Cosmetic Science·U ScherdinS Bielfeldt
Jul 12, 2008·Clinical Endocrinology·Helen MasonStephen L Atkin
Jul 18, 2000·Journal of the American Academy of Dermatology·G Webster
Jan 24, 2006·Clinics in Dermatology·Keyvan Nouri, Christopher J Ballard
Oct 27, 2005·The Journal of Dermatological Treatment·Suganthi ThevarajahAlan B Fleischer
Sep 17, 2004·The Journal of Dermatological Treatment·R C McHughS R Feldman
Jan 22, 2009·The Journal of Nervous and Mental Disease·Nicola BeattieCiaran Mulholland
Apr 3, 2009·Development and Psychopathology·Suzanne KingDavid P Laplante
Dec 10, 2009·The Journal of Nervous and Mental Disease·Ross G White, Andrew I Gumley
May 8, 2010·Psychiatry and Clinical Neurosciences·Daisuke NishiShigenobu Kanba
Apr 14, 2010·The Journal of Nervous and Mental Disease·Niall Crumlish, Killian O'Rourke
May 7, 2010·Health Physics·David BelyiVladimir Bebeshko
Sep 4, 2010·Journal of Developmental and Behavioral Pediatrics : JDBP·Lisa M IngerskiDavid M Janicke
Dec 25, 2010·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Inke R KönigGerd Schulte-Körne
Oct 7, 2005·The Journal of Nervous and Mental Disease·MarySue V HeilemannKathryn A Lee
Sep 19, 2009·Expert Opinion on Pharmacotherapy·Matt SagranskySteven R Feldman
Feb 6, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Ivan DzhagalovYou-Wen He
Apr 17, 2010·The Journal of Dermatological Treatment·Hamidreza Pazoki-ToroudiAlireza Firooz
Mar 23, 2000·Postgraduate Medicine·B A Johnson, J R Nunley
Feb 25, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Philip T LiuRobert L Modlin
Jun 20, 2020·Journal of Peptide Science : an Official Publication of the European Peptide Society·Tiaofei YeXueqing Xu
Sep 26, 2000·Journal of Cutaneous Medicine and Surgery·C G BurkhartP Lehmann
Mar 10, 2017·International Journal of Biological Macromolecules·Mohammad ShamsiSara Minaeian

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Related Papers

The New England Journal of Medicine
J J Leyden
Journal of the American Academy of Dermatology
G F Webster
Dermatology : International Journal for Clinical and Investigative Dermatology
H Gollnick, M Schramm
© 2021 Meta ULC. All rights reserved